Han J - Search Results

1

Predicting the Response of Neoadjuvant Chemotherapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer With Axillary Lymph Node Metastasis by Multigene Assay.

Lee JH, Ryu JM, Ahn JH, Cho SY, Lee SK, Yu J, Chae BJ, Nam SJ, Han J, Lee JE, Kim SW. Lee JH, et al. Among authors: han j. J Breast Cancer. 2022 Dec;25(6):473-484. doi: 10.4048/jbc.2022.25.e49. Epub 2022 Nov 18. J Breast Cancer. 2022. PMID: 36479604 Free PMC article.

2

MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer.

Han J, Choi YL, Kim H, Choi JY, Lee SK, Lee JE, Choi JS, Park S, Choi JS, Kim YD, Nam SJ, Nam BH, Kwon MJ, Shin YK. Han J, et al. Breast Cancer Res Treat. 2017 Jul;164(1):41-56. doi: 10.1007/s10549-017-4234-4. Epub 2017 Apr 13. Breast Cancer Res Treat. 2017. PMID: 28409241 Free PMC article.

3

A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2- early breast cancer.

Gong G, Kwon MJ, Han J, Lee HJ, Lee SK, Lee JE, Lee SH, Park S, Choi JS, Cho SY, Ahn SH, Lee JW, Cho SR, Moon Y, Nam BH, Nam SJ, Choi YL, Shin YK. Gong G, et al. Among authors: han j. Sci Rep. 2017 Mar 28;7:45554. doi: 10.1038/srep45554. Sci Rep. 2017. PMID: 28350001 Free PMC article.

4

BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer.

Kwon MJ, Lee SB, Han J, Lee JE, Lee JW, Gong G, Beitsch PD, Nam SJ, Ahn SH, Nam BH, Shin YK. Kwon MJ, et al. Among authors: han j. PLoS One. 2018 Nov 21;13(11):e0207155. doi: 10.1371/journal.pone.0207155. eCollection 2018. PLoS One. 2018. PMID: 30462685 Free PMC article.

5

Validation of the GenesWell BCT Score in Young Asian Women With HR+/HER2- Early Breast Cancer.

Kwon MJ, Ryu JM, Cho SY, Nam SJ, Kim SW, Lee J, Lee SJ, Park JY, Park HY, Hong S, Kim K, Han J, Moon Y, Shin YK, Lee JE. Kwon MJ, et al. Among authors: han j. Front Oncol. 2021 Feb 23;11:588728. doi: 10.3389/fonc.2021.588728. eCollection 2021. Front Oncol. 2021. PMID: 33708625 Free PMC article.

6

Targeted exome sequencing of Korean triple-negative breast cancer reveals homozygous deletions associated with poor prognosis of adjuvant chemotherapy-treated patients.

Jeong HM, Kim RN, Kwon MJ, Oh E, Han J, Lee SK, Choi JS, Park S, Nam SJ, Gong GY, Nam JW, Choi DH, Lee H, Nam BH, Choi YL, Shin YK. Jeong HM, et al. Among authors: han j. Oncotarget. 2017 Jun 27;8(37):61538-61550. doi: 10.18632/oncotarget.18618. eCollection 2017 Sep 22. Oncotarget. 2017. PMID: 28977883 Free PMC article.

7

Comparison of GenesWell BCT Score With Oncotype DX Recurrence Score for Risk Classification in Asian Women With Hormone Receptor-Positive, HER2-Negative Early Breast Cancer.

Kwon MJ, Lee JE, Jeong J, Woo SU, Han J, Kang BI, Kim JE, Moon Y, Lee SB, Lee S, Choi YL, Kwon Y, Song K, Gong G, Shin YK. Kwon MJ, et al. Among authors: han j. Front Oncol. 2019 Jul 24;9:667. doi: 10.3389/fonc.2019.00667. eCollection 2019. Front Oncol. 2019. PMID: 31404265 Free PMC article.

8

Matrix metalloproteinase 11 (MMP11) in macrophages promotes the migration of HER2-positive breast cancer cells and monocyte recruitment through CCL2-CCR2 signaling.

Kang SU, Cho SY, Jeong H, Han J, Chae HY, Yang H, Sung CO, Choi YL, Shin YK, Kwon MJ. Kang SU, et al. Among authors: han j. Lab Invest. 2022 Apr;102(4):376-390. doi: 10.1038/s41374-021-00699-y. Epub 2021 Nov 13. Lab Invest. 2022. PMID: 34775491 Free article.

9

High expression of NR1D1 is associated with good prognosis in triple-negative breast cancer patients treated with chemotherapy.

Na H, Han J, Ka NL, Lee MH, Choi YL, Shin YK, Lee MO. Na H, et al. Among authors: han j. Breast Cancer Res. 2019 Nov 28;21(1):127. doi: 10.1186/s13058-019-1197-x. Breast Cancer Res. 2019. PMID: 31779659 Free PMC article.

10

UBE2C Overexpression Aggravates Patient Outcome by Promoting Estrogen-Dependent/Independent Cell Proliferation in Early Hormone Receptor-Positive and HER2-Negative Breast Cancer.

Kim YJ, Lee G, Han J, Song K, Choi JS, Choi YL, Shin YK. Kim YJ, et al. Among authors: han j. Front Oncol. 2020 Jan 23;9:1574. doi: 10.3389/fonc.2019.01574. eCollection 2019. Front Oncol. 2020. PMID: 32039034 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30,366 results

Search Page